Skip to main content
Premium Trial:

Request an Annual Quote

Two Cents

The re-opened comment period for feedback to the US Food and Drug Administration on direct-to-consumer genetic testing ends today. The panel focused on molecular and clinical genetics, which is part of the medical devices committee, is seeking “input and comments from interested stakeholders to discuss scientific issues concerning DTC tests,” according to the Federal Register. At Genomes Unzipped, Luke Jostins urges his readers to share their thoughts with FDA. "The FDA needs to hear the full diversity of opinions and facts on this subject to make an informed decision," he writes. An older blog post from Dan Vorhaus at the Genomic Law Report adds that FDA will be following this comment period with town hall-style meetings, including one this week in Orlando, Fla.

HT: Razib Khan at Gene Expression

The Scan

Billions for Antivirals

The US is putting $3.2 billion toward a program to develop antivirals to treat COVID-19 in its early stages, the Wall Street Journal reports.

NFT of the Web

Tim Berners-Lee, who developed the World Wide Web, is auctioning its original source code as a non-fungible token, Reuters reports.

23andMe on the Nasdaq

23andMe's shares rose more than 20 percent following its merger with a special purpose acquisition company, as GenomeWeb has reported.

Science Papers Present GWAS of Brain Structure, System for Controlled Gene Transfer

In Science this week: genome-wide association study ties variants to white matter stricture in the brain, and more.